We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SBUX:NASDAQStarbucks Corporation Analysis

Data as of 2026-03-09 - not real-time

$99.77

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Starbucks is trading in a clear bullish technical environment – the price sits above the short‑term and long‑term moving averages, the MACD line is above its signal, and the RSI remains in the upper‑mid range, suggesting continued upward momentum. Support around the mid‑90s is holding firm while the stock approaches a key resistance near the high‑100s, and volume has remained stable, reinforcing the bullish bias. However, the recent announcement of new global tariffs introduced a short‑term headwind, prompting a noticeable intraday dip and adding regulatory uncertainty to the mix. Market sentiment is currently at an "Extreme Greed" level, indicating strong investor enthusiasm despite the policy risk. Fundamentally, the valuation appears stretched – the trailing P/E is exceptionally high and the discounted cash‑flow fair value is far below the current market price, while the price‑to‑book ratio is negative, reflecting a balance sheet that is not supporting the price. The dividend payout ratio exceeds 200%, raising concerns about the sustainability of the 2.5% yield. Nonetheless, the company's "Back to Starbucks" turnaround plan is showing early signs of traction, and its brand strength and global footprint remain solid. Analysts are split, with a median price target near the current level and a mix of neutral to buy recommendations, highlighting the tension between growth prospects and valuation concerns. Overall, the stock is positioned in a bullish technical setup but faces significant valuation and macro‑policy challenges.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish technical indicators with price above key moving averages
  • Recent price dip creates a potential entry point
  • Tariff uncertainty adds short‑term caution

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Turnaround initiatives beginning to show results
  • Valuation remains significantly above intrinsic estimates
  • Mixed analyst sentiment with neutral to buy ratings

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Strong brand and global presence support sustainable growth
  • High valuation and unsustainable dividend payout limit upside
  • Long‑term exposure to consumer cyclical dynamics and regulatory changes

Key Metrics & Analysis

Financial Health

Revenue Growth5.50%
Profit Margin3.63%
P/E Ratio83.1
ROA6.87%
P/B Ratio-13.5
Op. Cash Flow$4.3B
Free Cash Flow$-1439387520

Technical Analysis

TrendBullish
RSI61.7
Support$93.55
Resistance$101.20
MA 20$97.20
MA 50$93.68
MA 200$89.01
MACDBullish
VolumeStable
Fear & Greed Index75.89

Valuation

Fair Value$26.79
Target Price$100.06
Upside/Downside0.30%
GradeOvervalued
TypeGrowth
Dividend Yield2.51%

Risk Assessment

Beta1.05
Volatility27.30%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.